This article showcases a curated list of standout studies over the last week on topics such as cholesterol, GLP-1 drugs for ...

• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...

Less than 5% of hospitalized adults with type 2 diabetes received an SGLT2 inhibitor or GLP-1 before being discharged, ...

Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...

SLW: The part of dairy that is very well-positioned to assist consumers on their GLP-1 journey is yogurt. The functional ...

Varshavski: I asked a bunch of different specialists what's the one medical breakthrough they're excited about in their ...

Systemic medications, particularly selective beta blockers and calcium channel blockers, can significantly influence intraocular pressure (IOP) over time, according to study results published in ...

HealthDay News — Glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is not associated with an increased risk for thyroid cancer over the short term, according to a study published online Jan. 16 ...

Researchers found that GLP-1 RA use was not associated with an increased risk for thyroid cancer compared with use of DPP-4i. HealthDay News — Glucagon-like peptide 1 receptor agonist (GLP-1 RA) use ...

He called the high discontinuation rate among patients without T2D “striking,” as well as “reinforcing concerns that insurance barriers limit sustained use for those seeking GLP-1 RAs for ...

GLP-1RA use may raise the risk of hypotension and syncope. According to Dr Al-Aly’s team, careful monitoring of blood pressure and adjustment of antihypertensive medications may be needed. GLP-1 RA ...

As the use of GLP-1 medications explodes ... and heightened awareness on ultra-processed foods is leading some consumers to change their diets. Many analysts think the trend will accelerate ...